Back to blog

Daily Dilution Report - Mar 27, 2026

Published: 3/27/2026

All Events

$ANAB (MC: $1.8B)

- Stock Compensation: 11,250 RSUs granted to director, vesting over 3 years.
- Stock Repurchase: Board authorized $100M buyback of ANAB common stock.
- Terminated ATM: Prior ATM program no longer active for additional share sales.

View SEC Filing ->

$TWO (MC: $1.2B)

- Explanation:
- Merger Consideration: Each outstanding share of Two Harbors Common Stock will be converted into $10.80 in cash. This is a cash-out, not a dilution event for existing shareholders of common stock, as their shares are being purchased.
- RSUs: Cancelled and converted into the right to receive the Merger Consideration.

View SEC Filing ->

$UPB (MC: $529M)

- ATM Program: Up to $150M in common stock, est. 17.8M shares @ $8.45/share.
- Stock Options: 8.0M shares outstanding, WA exercise price $6.77/share.
- Future Stock Compensation: 3.5M shares for 2024 Option Plan, 0.5M shares for ESPP.

View SEC Filing ->

$ATLN (MC: $266M)

- Direct Offering: $5.6M gross proceeds from Convertible Preferred Stock and Warrants.
- Preferred Stock: $5.6M convertible @ $4.38/share (~1.28M potential shares).
- Warrants: Issued to purchase 5,600 Preferred Stock shares at an exercise price of $1,000/share, expiring March 20, 2026.

View SEC Filing ->

$UPB (MC: $529M)

- ATM Program for $150M.
- Underwriter: Leerink Partners LLC.

View SEC Filing ->

$CEPO (MC: $215M)

- Filing refers to future private placements; specific terms and share counts not yet available.
- Mentions convertible notes private placement and convertible preferred stock to be issued; details expected in future filings.

View SEC Filing ->

$KYTX (MC: $352M)

- ATM Offering: Up to $100M of common stock, 12.6M assumed shares at $7.94/share via Jefferies LLC.
- Equity Plans: 9.33M stock options ($4.77 avg exercise), 1.28M RSUs to vest.
- Incentive Shares: ~8.2M shares available/added for future issuance/awards under various incentive & purchase plans.

View SEC Filing ->

$ZBIO (MC: $989M)

- PIPE: 6.3M shares issued for ~$111.8M (Oct 2025).
- ATM: Up to ~$96.8M shares remain for sale via Sales Agreement.
- Equity awards: 10.7M stock options outstanding @ $13.46/share.

View SEC Filing ->

$ZBIO (MC: $989M)

- Proposed concurrent public offering & convertible notes (amounts/prices TBD).
- ATM program has ~$96.8M remaining available; 2.8M shares issued since 12/31/25.
- Over 22M shares possible from equity plans, options, RSUs & 2M direct issuance by 3/31/26.

View SEC Filing ->

$LPAA (MC: $308M)

- Working Capital Promissory Note with Sponsor, up to $1M, features 20% Original Issue Discount (OID) and 8% annual interest.
- Warrants (LPAAW) exercisable at $11.50/share; total number of shares not specified in this 8-K.

View SEC Filing ->

$OLPX (MC: $1.3B)

- Instead, the filing describes the conversion of existing equity awards into cash payments. This means existing shareholders and holders of equity awards will receive cash for their holdings rather than having their ownership diluted by new issuances.
- Here's an analysis of the equity-related items mentioned in the filing and why they are not considered stock dilution events:
- Company Equity Awards (Company Options and Company RSU Awards): These will be cancelled and converted into cash payments.

View SEC Filing ->

$WOLF (MC: $758M)

- Convertible Notes: $379M convertible @ ~$20.14/share (~22.59M potential shares)
- Warrants: Up to 2M shares purchasable via pre-funded warrants @ $0.01/share
- Private Placement: 3.25M shares offered @ $18.458/share

View SEC Filing ->